Identification of Active Molecules against Thrombocytopenia through Machine Learning
Journal of Chemical Information and Modeling · 26.08.2024 · 64 (16) · 6506-6520
DOI: 10.1021/acs.jcim.4c00718 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Chemical Information and Modeling, online erschienen am 07.08.2024. Verfasst von Youyou Yang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, School of Pharmacy, Southwest Medical University, Luzhou 646000, China. Hauptthemen laut MEDLINE: Machine Learning, Thrombocytopenia. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 59 Literaturangaben. Gefördert von: National College Students Innovation and Entrepreneurship Training Program, Chengdu University of Traditional Chinese Medicine, Science and Technology Department of Sichuan Province.
Abstract (Originalsprache)
Thrombocytopenia, which is associated with thrombopoietin (TPO) deficiency, presents very limited treatment options and can lead to life-threatening complications. Discovering new therapeutic agents against thrombocytopenia has proven to be a challenging task using traditional screening approaches. Fortunately, machine learning (ML) techniques offer a rapid avenue for exploring chemical space, thereby increasing the likelihood of uncovering new drug candidates. In this study, we focused on computational modeling for drug-induced megakaryocyte differentiation and platelet production using ML methods, aiming to gain insights into the structural characteristics of hematopoietic activity. We developed 112 different classifiers by combining eight ML algorithms with 14 molecule features. The top-performing model achieved good results on both 5-fold cross-validation (with an accuracy of 81.6% and MCC value of 0.589) and external validation (with an accuracy of 83.1% and MCC value of 0.642). Additionally, by leveraging the Shapley additive explanations method, the best model provided quantitative assessments of molecular properties and structures that significantly contributed to the predictions. Furthermore, we employed an ensemble strategy to integrate predictions from multiple models and performed in silico predictions for new molecules with potential activity against thrombocytopenia, sourced from traditional Chinese medicine and the Drug Repurposing Hub. The findings of this study could offer valuable insights into the structural characteristics and computational prediction of thrombopoiesis inducers.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Pharmacology, School of Pharmacy, Southwest Medical University, Luzhou 646000, China.
- School of Public Health, Southwest Medical University, Luzhou 646000, China.
- Basic Medical College, Southwest Medical University, Luzhou 646000, China.
- State Key Laboratory of Southwestern Chinese Medicine Resources, Chengdu University of Traditional Chinese Medicine, Chengdu 610075, China.
ORCID-Profile: Jiesi Luo
Förderung
- National College Students Innovation and Entrepreneurship Training Program
- Chengdu University of Traditional Chinese Medicine
- Science and Technology Department of Sichuan Province
Zitieren
APA
Yang, Y., Gan, W., Lin, L., Wang, L., Wu, J., & Luo, J. (2024). Identification of Active Molecules against Thrombocytopenia through Machine Learning. Journal of Chemical Information and Modeling, 64(16), 6506-6520. https://doi.org/10.1021/acs.jcim.4c00718
Vancouver
Yang Y, Gan W, Lin L, Wang L, Wu J, Luo J. Identification of Active Molecules against Thrombocytopenia through Machine Learning. Journal of Chemical Information and Modeling. 2024;64(16):6506-6520. doi:10.1021/acs.jcim.4c00718
BibTeX
@article{Yang2024,
author = {Yang, Youyou and Gan, Wenli and Lin, Lei and Wang, Long and Wu, Jianming and Luo, Jiesi},
title = {Identification of Active Molecules against Thrombocytopenia through Machine Learning},
journal = {Journal of Chemical Information and Modeling},
year = {2024},
volume = {64},
number = {16},
pages = {6506--6520},
doi = {10.1021/acs.jcim.4c00718}
}
EUVIMED